This announcement is a separate document:
片倉工業：連結子会社における中性脂肪蓄積心筋血管症治療薬「CNT-01」の国内第2b3相臨床試験解析結果(速報)のお知らせ
Katakura Industries: Announcements of individual stocks: Analysis results of domestic Phase 2b/3 clinical trial of "CNT-01", a therapeutic drug for neutral lipid accumulation cardiac vascular disease, in the consolidated subsidiary (preliminary report).
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.